Zurmo CRM CVE-2015-5365 HTML Injection Vulnerability
BID:75545
Info
Zurmo CRM CVE-2015-5365 HTML Injection Vulnerability
| Bugtraq ID: | 75545 |
| Class: | Input Validation Error |
| CVE: |
CVE-2015-5365 |
| Remote: | Yes |
| Local: | No |
| Published: | Jun 22 2015 12:00AM |
| Updated: | Jun 22 2015 12:00AM |
| Credit: | Provensec |
| Vulnerable: |
Zurmo Zurmo CRM 3.0.2 |
| Not Vulnerable: | |
Discussion
Zurmo CRM CVE-2015-5365 HTML Injection Vulnerability
Zurmo CRM is prone to an HTML-injection vulnerability because it fails to properly sanitize user-supplied input before using it in dynamically generated content.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and to launch other attacks.
Zurmo CRM 3.0.2 is vulnerable; other versions may also be affected.
Zurmo CRM is prone to an HTML-injection vulnerability because it fails to properly sanitize user-supplied input before using it in dynamically generated content.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and to launch other attacks.
Zurmo CRM 3.0.2 is vulnerable; other versions may also be affected.
Exploit / POC
Zurmo CRM CVE-2015-5365 HTML Injection Vulnerability
Attackers can exploit this issue by enticing an unsuspecting victim to follow a malicious URI.
Attackers can exploit this issue by enticing an unsuspecting victim to follow a malicious URI.
Solution / Fix
Zurmo CRM CVE-2015-5365 HTML Injection Vulnerability
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].